Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DRNA

Dicerna Pharmaceuticals (DRNA) Stock Price, News & Analysis

Dicerna Pharmaceuticals logo

About Dicerna Pharmaceuticals Stock (NASDAQ:DRNA)

Advanced Chart

Key Stats

Today's Range
$38.22
$38.22
50-Day Range
$37.81
$38.25
52-Week Range
$19.06
$40.14
Volume
N/A
Average Volume
1.34 million shs
Market Capitalization
$2.99 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DRNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dicerna Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

DRNA Stock News Headlines

Arrowhead Pharmaceuticals (NASDAQ: ARWR)
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
DRNA Jan 2022 22.500 call
DRNA Jul 2022 40.000 call(CONTR
See More Headlines

DRNA Stock Analysis - Frequently Asked Questions

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) released its quarterly earnings results on Tuesday, November, 9th. The biopharmaceutical company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.41) by $0.19. The biopharmaceutical company had revenue of $62.95 million for the quarter, compared to analyst estimates of $58.83 million. Dicerna Pharmaceuticals had a negative net margin of 64.53% and a negative trailing twelve-month return on equity of 103.08%.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dicerna Pharmaceuticals investors own include Axsome Therapeutics (AXSM), Bristol Myers Squibb (BMY), NVIDIA (NVDA), Marvell Technology (MRVL), Advanced Micro Devices (AMD), Gilead Sciences (GILD) and PayPal (PYPL).

Company Calendar

Last Earnings
11/09/2021
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:DRNA
Employees
302
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$112.75 million
Pretax Margin
-63.82%

Debt

Sales & Book Value

Annual Sales
$164.31 million
Price / Cash Flow
N/A
Book Value
$1.84 per share
Price / Book
20.77

Miscellaneous

Free Float
70,160,000
Market Cap
$2.99 billion
Optionable
Optionable
Beta
0.80

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:DRNA) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners